Lung Non-Small Cell Carcinoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB12267 | Brigatinib | 0 | Recruiting | 1 |
| DB11714 | Durvalumab | 1 | Recruiting | 1 |
| DB01113 | Papaverine | 1 | Recruiting | 1 |
| DB06132 | Nivolumab | 1 / 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 / 2 | Recruiting | 1 |
| DB09330 | Osimertinib | 1 / 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 2 |
| DB15232 | Telaglenastat | 1 / 2 | Recruiting | 1 |
| DB00112 | Bevacizumab | 2 | Recruiting | 1 |
| DB09330 | Osimertinib | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB06645 | Anamorelin | 2 / 3 | Recruiting | 1 |
| DB06186 | Ipilimumab | 3 | Recruiting | 1 |
| DB09035 | Nivolumab | 3 | Recruiting | 1 |